in 1976, a national influenza campaign was designed to immunize nearly the
entire United States population in fear of an influenza pandemic. However, the
A/New Jersey/1976/H1N1 vaccine, also known as the "swine flu" vaccine, was found
to be linked with the development of Guillain-Barré syndrome (GBS) and the
program ended. This study was conducted to find the relationship between the
vaccine and GBS effects.
In 2004 investigators at CDC
collaborated with the department of Pathology and Laboratory Medicine,
University of Pennsylvania School of Medicine, Philadelphia, and the Department
of Microbiology, National University of Ireland, Galway, to investigate anti-ganglioside
antibody induction by swine flu and other influenza vaccines.
The following article explains the Immunization Safety Office's role in this initiative.
- "Swine Flu and Associated Guillain-Barré Syndrome"
This study covers the methods, hypotheses, results, and limitations
studied in regards to the swine flu vaccination. The study focuses on the immunization to the swine
flu and how it was found to be linked to Guillain-Barré Syndrome (GBS).
Complete List of Articles
*Links to non-Federal organizations found at this site are provided solely as a
service to our users. These links do not constitute an endorsement of these organizations or their
programs by CDC or the Federal Government, and none should be inferred. CDC is not responsible
for the content of the individual organization Web pages found at these links.